MyFinsight
Home
Blog
About
Parasiticides
$698M
(3.71%↑ Y/Y)
Vaccines
$521M
(3.37%↑ Y/Y)
Dermatology
$398M
(-14.04%↓ Y/Y)
Anti Infective
Products
$244M
(11.42%↑ Y/Y)
Pain Sedation
$217M
(0.00%↑ Y/Y)
Other
Pharmaceuticals
$168M
(-2.33%↓ Y/Y)
Animal Health
Diagnostics
$123M
(11.82%↑ Y/Y)
Other Non
Pharmaceuticals
$70M
(11.11%↑ Y/Y)
Total Productsand
Services
$2,439M
(0.54%↑ Y/Y)
Contract
Manufacturingand Human Health...
$29M
(-14.71%↓ Y/Y)
Revenue
$2,468M
(0.33%↑ Y/Y)
Other
(income)/deductionsnet
$5M
(225.00%↑ Y/Y)
Income before
provision for taxes on...
$866M
(-3.99%↓ Y/Y)
Cost of sales
$673M
(3.70%↑ Y/Y)
Selling, general and
administrative expenses
$592M
(-4.05%↓ Y/Y)
Research and development
expenses
$173M
(0.58%↑ Y/Y)
Restructuring charges and
certain acquisition and...
$77M
(156.67%↑ Y/Y)
Interest expense, net of
capitalized interest
$61M
(15.09%↑ Y/Y)
Amortization of intangible
assets
$31M
(-6.06%↓ Y/Y)
Net income before
allocation to...
$691M
(-3.76%↓ Y/Y)
Provision for taxes on
income
$175M
(-4.89%↓ Y/Y)
Net income
attributable to zoetis inc
$691M
(-3.76%↓ Y/Y)
Back
Back
Income Statement
zoetis-investors-svg
Zoetis Inc. (ZTS)
zoetis-investors-svg
Zoetis Inc. (ZTS)
source: myfinsight.com